Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G McCauley

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
Nature Communications|September 16, 2024
Targeted transcriptional downregulation of MYC using epigenomic controllers demonstrates antitumor activity in hepatocellular carcinoma modelsWilliam Senapedis, Kayleigh M Gallagher, Elmer Figueroa, et al.
Chemistry & Biology|January 25, 2005
Direct in vitro selection of a 2'-O-methyl aptamer to VEGFPaula E Burmeister, Scott D Lewis, Robert F Silva, et al.
Oligonucleotides|December 13, 2006
2'-Deoxy purine, 2'-O-methyl pyrimidine (dRmY) aptamers as candidate therapeuticsPaula E Burmeister, Chunhua Wang, Jason R Killough, et al.
Nature Communications|March 14, 2025
Programmable mRNA therapeutics for controlled epigenomic modulation of single and multiplexed gene expression in diverse diseasesCharles W O'Donnell, Jeremiah D Farelli, Houda Belaghzal, et al.
Nature|November 7, 2008
Accurate whole human genome sequencing using reversible terminator chemistryDavid R Bentley, Shankar Balasubramanian, Harold P Swerdlow, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
Nature Communications|September 16, 2024
Targeted transcriptional downregulation of MYC using epigenomic controllers demonstrates antitumor activity in hepatocellular carcinoma modelsWilliam Senapedis, Kayleigh M Gallagher, Elmer Figueroa, et al.
Chemistry & Biology|January 25, 2005
Direct in vitro selection of a 2'-O-methyl aptamer to VEGFPaula E Burmeister, Scott D Lewis, Robert F Silva, et al.
Oligonucleotides|December 13, 2006
2'-Deoxy purine, 2'-O-methyl pyrimidine (dRmY) aptamers as candidate therapeuticsPaula E Burmeister, Chunhua Wang, Jason R Killough, et al.
Nature Communications|March 14, 2025
Programmable mRNA therapeutics for controlled epigenomic modulation of single and multiplexed gene expression in diverse diseasesCharles W O'Donnell, Jeremiah D Farelli, Houda Belaghzal, et al.
Nature|November 7, 2008
Accurate whole human genome sequencing using reversible terminator chemistryDavid R Bentley, Shankar Balasubramanian, Harold P Swerdlow, et al.
Pageof 7